review of glp-1 and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 Agonists For Obesity In

PMID: 14523363

PubMed laboratory research record [PMID: 17132710] PubMed record related to this compound for laboratory literature review

The NCE period for tirzepatide runs through May 13, 2027, which means generic companies may not file an ANDA seeking approval for a generic version of Mounjaro or Zepbound until May 13, 2026, with patent infringement lawsuits expected to occur in the following months

Specific Application Scenarios in Anti-Aging Research Based on its clear mechanism of action and formulation advantages, 5-amino-1mq capsules have been widely used in anti-aging studies at the cellular and animal levels, covering multiple aging-related fields and providing abundant experimental data for exploring anti-aging intervention strategies

Dysbiosis signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity

Diabetes 1999